SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Thyroid Meds Recalled Nationwide; Life Expectancy Rebounds; Cannabis Use Hits Record

Health news and commentary gathered by MedPage Today staff

The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

The $50 price under the program applies only to people using the drug solely for weight loss

'Gray Market' Retatrutide Study; Menopause and the Brain; Drug Allergy Warnings

News and commentary from the endocrinology world

FDA Authorizes First Wearable Dual Glucose-Ketone Sensor

System offers real-time diabetic ketoacidosis warnings

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Health news and commentary gathered by MedPage Today staff

The $50 price under the program applies only to people using the drug solely for weight loss

News and commentary from the endocrinology world

System offers real-time diabetic ketoacidosis warnings

News All Time

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Body-Related TikTok Reels Tied to Self-Objectification, Mood

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Recommended News For You

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

Recommended Articles For You

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review 

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

The Link Between Being Overweight and Cancer 

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

2.

In prostate cancer survivorship, sleep disturbances are underappreciated.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Study finds 81% of cancer cures touted by TikTok videos are fake

5.

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

1.

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025

2.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

3.

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients

4.

Preventing Functional Iron Deficiency in High-Risk Populations

5.

Red Blood Cell Aging and Clinical Implications

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Navigating the Complexities of Ph Negative ALL - Part XVI

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot